 Company Regains Compliance with NASDAQ Minimum Bid Requirement IRVINE, CA ACCESSWIRE December 21, 2020 Hancock Jaffe Laboratories, Inc. NASDAQ:HJLI, a developer of medical devices that restore cardiac and vascular health, today announced that the Company has received formal notification from the NASDAQ Hearings Panel the Panel that the Company has evidenced full compliance with the minimum bid price requirement and all other applicable criteria for continued listing on The NASDAQ Stock Market, that all compliance matters have been resolved, and that the Panel has closed the HJLI compliance file. To evidence compliance with the minimum bid requirement, the Company needed to evidence a closing bid price of at least 1.00 per share for a minimum of ten, but generally not more than 20, consecutive business days. 